ClinConnect ClinConnect Logo
Search / Trial NCT00001464

Effect of High Levels of Oxygen and Smoking on the Lungs in Human Volunteers

Launched by NATIONAL HEART, LUNG, AND BLOOD INSTITUTE (NHLBI) · Nov 3, 1999

Trial Information

Current as of March 23, 2025

Completed

Keywords

Oxygen Bronchoalveolar Lavage Dna Repair Carbonyl Groups Serum Human Volunteers

ClinConnect Summary

Stress such as high oxygen or inflammation can result in damage to proteins by processes such as oxidation or alternative regulation of signaling pathways by post-translational modification of proteins (e.g., phosphorylation). Delivery of oxygen in high concentrations to the lungs can result in damage, which is mediated in large part by reactive oxygen species. Inflammation can result in activation of intracellular signaling pathways. This study will evaluate modification of proteins and nucleic acids in bronchoalveolar lavage fluid, bronchial epithelial cells, and peripheral blood of indiv...

Gender

ALL

Eligibility criteria

  • * INCLUSION CRITERIA:
  • History - good overall health without history of recent (within 3 months) acute disease;
  • Physical examination within normal limits;
  • Laboratory evaluation; including complete blood count (CBC), serum electrolyte determinations, clotting times, chest x-ray, pulmonary function testing, and an electrocardiogram (EKG) - within normal limits;
  • Non-smokers defined as having never smoked or not smoked in the past 2 years;
  • Smokers defined as moderate (1 pack per day for 3+ years) or heavy (1-2 packs for 10+ years);
  • Subjects must be willing to make the time commitment necessary for the study.
  • EXCLUSION CRITERIA:
  • Any study subject who does not fulfill the criteria for eligibility.
  • Individuals with a history of allergy or adverse reactions to atropine or any local anesthetic;
  • Individuals testing positive for the human immunodeficiency virus or hepatitis virus;
  • Individuals on chronic medications or currently receiving medications;
  • Pregnant or lactating individuals, since the effects of hyperoxia on the fetus are unclear.

Trial Officials

Joel Moss, M.D.

Principal Investigator

National Heart, Lung, and Blood Institute (NHLBI)

About National Heart, Lung, And Blood Institute (Nhlbi)

The National Heart, Lung, and Blood Institute (NHLBI) is a leading component of the National Institutes of Health (NIH), dedicated to advancing research and clinical trials focused on cardiovascular, pulmonary, and hematologic diseases. With a mission to improve public health through innovative research, the NHLBI supports a wide range of studies aimed at understanding, preventing, and treating heart and lung conditions. By collaborating with academic institutions, healthcare providers, and patient communities, the NHLBI strives to translate scientific discoveries into effective clinical practices, ultimately enhancing the quality of life for individuals affected by these critical health issues.

Locations

Bethesda, Maryland, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials